Pharmaceuticals (Basel)
October 2024
This review examines the evolution of lyotropic liquid crystals (LLCs) in ocular drug delivery, focusing on their ability to address the challenges associated with traditional ophthalmic formulations. This study aims to underscore the enhanced bioavailability, prolonged retention, and controlled release properties of LLCs that significantly improve therapeutic outcomes. This review synthesizes data from various studies on both bulk-forming LLCs and liquid crystal nanoparticles (LCNPs).
View Article and Find Full Text PDF